This interesting work explores the relationship between the legal protection afforded to the technical field of the innovative pharmaceutical industry through industrial property privileges and access to health care as a human right and constitutional guarantee. Industrial property law in general, and patent law in particular, constitute a fundamental aspect of economic development and the promotion of innovation in the pharmaceutical industry.In this respect, it is well known that such regulation represents a great contribution to the balance between, on the one hand, the private interest of those who allocate resources and time to research and develop innovative technology and, on the other hand, the public interest of society regarding the benefit of having access to it, in this case, access to medicines, leading the inventor to disclose, for the benefit of the public, the knowledge that he would otherwise keep secret.Undoubtedly, a reading that cannot be missed in times of pandemic, in which Industrial Property plays a key role, both from the legal protection for successful medicines, as well as from the tools that would allow guaranteeing their access.